Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medtronic

Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market

On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures.

Benzinga

Employers efforts recognised as gender pay gap narrows

Australia's overall gender pay gap has narrowed, but among CEO's there has been an increase - showing the need for further commitment at top levels.

AAP

Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum

Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

This Medical Device Maker Is Seeing High Demand In Cardiovascular, Diabetes Business

Medtronic Plc (NYSE:MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase year-over-year, with organic growth of 5.5%.

Benzinga

Option Volatility and Earnings Report for November 17 - 21

It’s a big week for earnings this week with Nvidia and some key retail names taking center stage. This week we have Nvidia, Home Depot, Walmart, Target, Lowes, Palo Alto Networks, Medtronic and Pdd Holdings all reporting.

Barchart

Is Wall Street Bullish or Bearish on Medtronic Stock?

Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Barchart

What to Expect From Medtronic's Q2 2026 Earnings Report

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women

Medtronic plc (NYSE:MDT) Wednesday announced the commencement of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to assess the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures.

Benzinga

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Benzinga

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga

Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair Trial

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.

Benzinga

Medtronic Stock: Is MDT Outperforming the Healthcare Sector?

Medtronic has significantly outperformed the broader healthcare sector over the past year and in recent months, and analysts remain bullish on the stock’s prospects.

Barchart

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc (NYSE:MDT) posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.

Benzinga

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.

MarketBeat

Medtronic: The Opportunity Gets Healthier for Income Investors

Medtronic is on track to complete a market reversal in 2025. Sell-siders, including activists, analysts, and institutions, are buying this stock in 2025.

Benzinga

Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift

Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately. This move comes shortly after Elliott Investment Management became the company’s largest shareholder.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stock Index Futures Muted as Focus Turns to Retail Earnings, U.S. Housing Data Awaited

September S&P 500 E-Mini futures (ESU25) are down -0.09%, and September Nasdaq 100 E-Mini futures (NQU25) are down -0.08% this morning as earnings from the nation’s retail heavyweights kicked off, shifting the focus to the strength of the American consumer.

Benzinga

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Medtronic plc (NYSE:MDT) will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.

Barchart

Are Wall Street Analysts Bullish on Medtronic Stock?

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its future growth prospects.

Barchart

Here's What to Expect From Medtronic's Next Earnings Report

Medtronic is all set to release its fiscal first-quarter earnings later next month, and analysts project earnings in line with the year-ago quarter.

Benzinga

Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent related to the implantation of artificial heart valves.

MarketBeat

5 Robotics Stocks to Buy for the Future of Automation

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

Benzinga

Medtronic Stock Is Climbing Friday: What's Going On?

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.